Hendrix Yvette M G A, Sier Misha A T, Baas Melanie A M, van Pampus Maria G
Department of Obstetrics and Gynecology, OLVG, Amsterdam, the Netherlands.
Department of Surgery, Franciscus Gasthuis, Rotterdam, the Netherlands.
J Trauma Stress. 2022 Oct;35(5):1420-1431. doi: 10.1002/jts.22842. Epub 2022 May 10.
There is no consensus on the treatment of posttraumatic stress disorder (PTSD) during pregnancy, and therapists' views on the matter are largely unknown. This cross-sectional study aimed to explore therapist beliefs and experiences regarding PTSD treatment during pregnancy. Participants were therapists (N = 301) with experience treating PTSD who completed an online survey. The primary outcome measure was the percentage of therapists who were experienced in treating PTSD symptoms during pregnancy; secondary outcome measures assessed preferred treatments for the general and pregnant populations, perceived reluctance to treat PTSD in pregnancy, and perceived effects and adverse events attributed to treatment for pregnant women and fetuses. The majority of participants (n = 246, 81.7%) had experience with treating PTSD during pregnancy. Eye movement desensitization and reprocessing was the preferred treatment for both the general and the pregnant populations. Almost half of the sample (48.8%) reported hearing that PTSD treatment in pregnancy could be harmful; 30.5% of therapists were reluctant to treat pregnant women with PTSD. Most therapists observed a clinically relevant posttreatment reduction of PTSD symptoms in pregnant women. Perceived adverse maternal and fetal events attributed to treatment were reported by 8.4% and 1.4% of therapists, respectively. Despite reluctance, most therapists reported treating PTSD during pregnancy. The results show that although therapists often reported hearing that treating PTSD during pregnancy was harmful, only a small percentage reported perceived adverse events, and treatment was often viewed as effective. These findings implicate a more positive view on the treatment of PTSD in pregnancy.
对于孕期创伤后应激障碍（PTSD）的治疗尚无共识，治疗师对此事的看法也大多不为人知。这项横断面研究旨在探讨治疗师对孕期PTSD治疗的看法和经验。参与者为有PTSD治疗经验的治疗师（N = 301），他们完成了一项在线调查。主要结局指标是有孕期PTSD症状治疗经验的治疗师的百分比；次要结局指标评估了针对一般人群和孕妇的首选治疗方法、对孕期治疗PTSD的顾虑、以及对孕妇和胎儿治疗效果及不良事件的认知。大多数参与者（n = 246，81.7%）有孕期治疗PTSD的经验。眼动脱敏再处理疗法是一般人群和孕妇的首选治疗方法。近一半的样本（48.8%）报告听说孕期PTSD治疗可能有害；30.5%的治疗师不愿治疗患有PTSD的孕妇。大多数治疗师观察到孕妇治疗后PTSD症状在临床上有显著减轻。分别有8.4%和1.4%的治疗师报告了与治疗相关的母体和胎儿不良事件。尽管有所顾虑，但大多数治疗师报告在孕期治疗PTSD。结果表明，尽管治疗师经常听说孕期治疗PTSD有害，但只有一小部分报告了察觉到的不良事件，而且治疗通常被认为是有效的。这些发现意味着对孕期PTSD治疗有更积极的看法。
